Evidence map›Paper›PMID 36063343›Full record

ArticleRheumatology and therapy2022

Correction to: Real-World Effectiveness and Treatment Retention of Secukinumab in Patients with Psoriatic Arthritis and Axial Spondyloarthritis: A Descriptive Observational Analysis of the Spanish BIOBADASER Registry.

Manuel José Moreno-Ramos, Carlos Sanchez-Piedra, Olga Martínez-González, Carlos Rodríguez-Lozano, Carolina Pérez-Garcia, Mercedes Freire, Cristina Campos, Rafael Cáliz-Caliz, Jerusalem Calvo, Juan María Blanco-Madrigal and 6 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Rheumatology and therapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Manuel José Moreno-RamosHospital Clínico Universitario Virgen de la Arrixaca, El Palmar, Spain.
Carlos Sanchez-PiedraSociedad Española de Reumatología, Madrid, Spain.
Olga Martínez-GonzálezHospital Universitario de Salamanca, Salamanca, Spain.
Carlos Rodríguez-LozanoHospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain.
Carolina Pérez-GarciaHospital del Mar, Barcelona, Spain.
Mercedes FreireComplejo Hospitalario Universitario A Coruña, A Coruña, Spain.
Cristina CamposHospital General Universitario de Valencia, Valencia, Spain.
Rafael Cáliz-CalizHospital Universitario Virgen de las Nieves, Granada, Spain.
Jerusalem CalvoHospital Universitario Reina Sofía, Córdoba, Spain.
Juan María Blanco-MadrigalHospital Universitario de Basurto, Bilbao, Spain.
Ana Pérez-GómezHospital Universitario Príncipe de Asturias, Alcalá de Henares, Spain.
María José Moreno-MartínezHospital Rafael Méndez, Lorca, Spain. mjmorenomartinez@gmail.com.
Luis LinaresHospital Clínico Universitario Virgen de la Arrixaca, El Palmar, Spain.
Fernando Sánchez-AlonsoSociedad Española de Reumatología, Madrid, Spain.
Carlos SastréNovartis Farmacéutica S.A., Barcelona, Spain.
Isabel CastrejónHospital General Universitario Gregorio Marañón, Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36063343
PMCPMC9510073

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.